BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 31209199)

  • 1. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis.
    Tsurusaki S; Tsuchiya Y; Koumura T; Nakasone M; Sakamoto T; Matsuoka M; Imai H; Yuet-Yin Kok C; Okochi H; Nakano H; Miyajima A; Tanaka M
    Cell Death Dis; 2019 Jun; 10(6):449. PubMed ID: 31209199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Analysis of Necrosis and Ferroptosis in Nonalcoholic Steatohepatitis (NASH).
    Tsurusaki S; Kanegae K; Tanaka M
    Methods Mol Biol; 2022; 2455():267-278. PubMed ID: 35213001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
    Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
    J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis.
    Liu B; Yi W; Mao X; Yang L; Rao C
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E925-E937. PubMed ID: 33813878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice.
    Qi J; Kim JW; Zhou Z; Lim CW; Kim B
    Am J Pathol; 2020 Jan; 190(1):68-81. PubMed ID: 31610178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
    Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
    J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
    Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
    Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
    J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice.
    Fourcot A; Couchie D; Chobert MN; Zafrani ES; Mavier P; Laperche Y; Brouillet A
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1043-53. PubMed ID: 21350191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
    Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.
    Tao L; Yi Y; Chen Y; Zhang H; Orning P; Lien E; Jie J; Zhang W; Xu Q; Li Y; Ding Z; Wu C; Ding Q; Wang J; Zhang J; Weng D
    Cell Death Differ; 2021 Apr; 28(4):1418-1433. PubMed ID: 33208891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin I
    Kumei S; Yuhki KI; Kojima F; Kashiwagi H; Imamichi Y; Okumura T; Narumiya S; Ushikubi F
    FASEB J; 2018 May; 32(5):2354-2365. PubMed ID: 29247122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death.
    Briand F; Heymes C; Bonada L; Angles T; Charpentier J; Branchereau M; Brousseau E; Quinsat M; Fazilleau N; Burcelin R; Sulpice T
    Clin Transl Sci; 2020 May; 13(3):529-538. PubMed ID: 31981449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial-Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis.
    Yan M; Li H; Xu S; Wu J; Li J; Xiao C; Mo C; Ding BS
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.
    Yuan X; Li L; Zhang Y; Ai R; Li D; Dou Y; Hou M; Zhao D; Zhao S; Nan Y
    Lipids Health Dis; 2023 Jul; 22(1):99. PubMed ID: 37422643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.